Labcorp Stock Gains From Its Latest Acquisition of BioReference Health [Yahoo! Finance]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: Yahoo! Finance
LH recently announced the completion of its acquisition of select assets of BioReference Health — a wholly-owned subsidiary of OPKO Health, Inc. (OPK). The transaction is aimed at providing customers with greater access to Labcorp's comprehensive, high-quality laboratory services, scientific expertise and expanded testing capabilities in key regions across the United States. Likely Trend of LH Stock Following the News Following the announcement, shares of Labcorp rose 2.1% to $225.76 yesterday. The company continues to gain a high level of synergies from its various new collaborations and acquisitions within the clinical laboratory service space. Accordingly, we expect market sentiment toward LH stock to continue to remain positive, driven by this announcement. Details on LabCorp's Acquisition of BioReference Health The terms of acquisition include BioReference Health's laboratory testing businesses. The laboratory testing business is focused on clinical diagnostics and reprod
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.MarketBeat
- OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical DevelopmentGlobeNewswire
- Greenberg Traurig Advises OPKO Health in $237.5 Million Asset Sale to LabcorpPR Web
- OPKO Health, Inc. (NASDAQ: OPK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $2.25 price target on the stock.MarketBeat
- OPKO Health, Inc. (NASDAQ: OPK) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock.MarketBeat
OPK
Earnings
- 8/7/24 - Beat
OPK
Sec Filings
- 9/27/24 - Form 4
- 9/27/24 - Form 4/A
- 9/26/24 - Form 4
- OPK's page on the SEC website